Mayr C - Search Results

1

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, Hallek M, Wendtner CM. Mayr C, et al. Blood. 2006 Jan 15;107(2):742-51. doi: 10.1182/blood-2005-05-2093. Epub 2005 Sep 22. Blood. 2006. PMID: 16179374 Free article.

2

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.

Mayr C, Bund D, Schlee M, Moosmann A, Kofler DM, Hallek M, Wendtner CM. Mayr C, et al. Blood. 2005 Feb 15;105(4):1566-73. doi: 10.1182/blood-2004-04-1233. Epub 2004 Oct 7. Blood. 2005. PMID: 15471955 Free article.

3

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.

Mayr C, Kofler DM, Büning H, Bund D, Hallek M, Wendtner CM. Mayr C, et al. Blood. 2005 Nov 1;106(9):3223-6. doi: 10.1182/blood-2005-04-1742. Epub 2005 Jul 12. Blood. 2005. PMID: 16014560 Free article.

4

MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.

Mayr C, Bund D, Schlee M, Bamberger M, Kofler DM, Hallek M, Wendtner CM. Mayr C, et al. Exp Hematol. 2006 Jan;34(1):44-53. doi: 10.1016/j.exphem.2005.09.016. Exp Hematol. 2006. PMID: 16413390 Free article.

5

Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cells.

Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM. Bund D, et al. Among authors: mayr c. Exp Hematol. 2006 Jul;34(7):860-9. doi: 10.1016/j.exphem.2006.04.010. Exp Hematol. 2006. PMID: 16797413 Free article.

6

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.

Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, Schultze JL, Hallek M, Wendtner CM. Pallasch CP, et al. Among authors: mayr c. Blood. 2009 Oct 8;114(15):3255-64. doi: 10.1182/blood-2009-06-229898. Epub 2009 Aug 19. Blood. 2009. PMID: 19692702 Free PMC article.

7

CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.

Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM. Bund D, et al. Among authors: mayr c. Exp Hematol. 2007 Jun;35(6):920-30. doi: 10.1016/j.exphem.2007.03.001. Exp Hematol. 2007. PMID: 17533046 Clinical Trial.

8

Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors.

Kofler DM, Büning H, Mayr C, Bund D, Baumert J, Hallek M, Wendtner CM. Kofler DM, et al. Among authors: mayr c. Gene Ther. 2004 Sep;11(18):1416-24. doi: 10.1038/sj.gt.3302279. Gene Ther. 2004. PMID: 15269708

9

The potential of gene transfer into primary B-CLL cells using recombinant virus vectors.

Wendtner CM, Kofler DM, Mayr C, Bund D, Hallek M. Wendtner CM, et al. Among authors: mayr c. Leuk Lymphoma. 2004 May;45(5):897-904. doi: 10.1080/10428190310001638896. Leuk Lymphoma. 2004. PMID: 15291346 Review.

10

Current status of immunotherapy in B cell malignancies.

Kofler DM, Mayr C, Wendtner CM. Kofler DM, et al. Among authors: mayr c. Curr Drug Targets. 2006 Oct;7(10):1371-4. doi: 10.2174/138945006778559120. Curr Drug Targets. 2006. PMID: 17073599 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters